Form 4: Zymeworks Inc. Executive Granted Stock Options

Zymeworks Inc. grants stock options to an executive, vesting after the next annual general meeting.

Summary

• Zymeworks Inc. granted stock options to Nancy C. Davidson on December 10, 2024.
• The options allow the purchase of 31,000 shares of common stock at a price of $13.06 per share.
• These stock options will vest on the date of the next annual general meeting following the grant date.
• The options expire on December 9, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock options to executives, which is generally viewed positively as it aligns interests. There are no indications of negative sentiment.

Positives

• The granting of stock options can serve as an incentive for the executive to perform well.
• The vesting period aligns the executive's interests with the long-term success of the company.

Risks

• The value of the stock options is dependent on the future performance of Zymeworks Inc.'s stock price.
• If the stock price does not increase above the exercise price, the options may not be valuable to the executive.

Future Outlook

The stock options will vest after the next annual general meeting following the grant date, aligning the executive's interests with the company's future performance.

Industry Context

Granting stock options is a common practice in the biotechnology industry to attract and retain key executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry, often used to incentivize performance and align interests with shareholders.
• The vesting schedule, tied to the annual general meeting, is a typical approach to ensure long-term commitment from the executive.
• The exercise price of $13.06 is a specific value that would need to be compared to other similar grants in the industry to assess its competitiveness.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes executive performance.
• The executive benefits from the potential for future gains if the stock price increases.

Next Steps

• The stock options will vest after the next annual general meeting following the grant date.

Key Dates

Keywords

stock options, equity compensation, executive compensation, vesting, Zymeworks Inc., ZYME